 KELOWNA, BC ACCESSWIRE January 8, 2021 Lexaria Bioscience Corp. OTCQX:LXRPCSE:LXX the Company or Lexaria, a global innovator in drug delivery platforms, today announced that it intends to effect a reverse stock split of its common stock effective as of 4:30 pm EST on January 11, 2021 the Reverse Split. The Reverse Split will be conducted on a 1-for-30 basis resulting in the Companys current issued share capital of 90,044,312 shares of common stock being consolidated into 3,001,377 shares of common stock, subject to adjustment for fractional shares which will be rounded to the nearest whole number. 